Synthesis and structure -: Activity relationship studies of 3,6-diazabicyclo[3.2.0]heptanes as novel α4β2 nicotinic acetylcholine receptor selective Agonists

被引:37
|
作者
Ji, Jianguo
Schrimpf, Michael R.
Sippy, Kevin B.
Bunnelle, William H.
Li, Tao
Anderson, David J.
Faltynek, Connie
Surowy, Carol S.
Dyhring, Tino
Ahring, Philip K.
Meyer, Michael D.
机构
[1] Nuerosci Res, Abbott Pk, IL 60064 USA
[2] NeuroSearch A S, Ballerup, Denmark
关键词
D O I
10.1021/jm070755h
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of novel, potent neuronal nicotinic acetylcholine receptor (nAChR) ligands derived from 3,6-diazabicyclo[3.2.0]heptane have been synthesized and evaluated for binding affinity and agonist activity at the alpha 4 beta 2 nAChR subtype. Structure- activity relationship studies of these novel nAChR ligands focused on substitution effects on the pyridine ring, as well as stereo- and regiochemical influences of the 3,6-diazabicyclo[3.2.0]heptane core. Small 5-substituents on the pyridine ring had a modest impact on the binding affinities and functional activities. 6-Bromo, 6-chloro, and 6-methyl substituents on the pyridine ring led to increased binding affinities and improved functional activities. Most of the 6-N-pyridinyl -substituted 3,6-diazabicyclo[3.2.0]heptanes are selective for the alpha A beta 2 nAChR subtype. Compounds (IR,5S)-25, (I R,5S)55, and (I R,5S)-56 were virtually inactive as agonists at the h alpha 3 beta 4 nAChR but retained potency and efficacy at the h alpha 4 beta 2 nAChR subtype. 3-N-Pyridinyl-substituted series demonstrated more complex SAR. (IR,5R)39, (1R,5R)-41, and (IR,5R)-42 were found to be much more potent at the h alpha 3 beta 4.nAChR subtype, whereas (IR,5R)-38 and (JR,5R)-40 were very selective at the h alpha 4 beta 2 nAChR subtype. The SAR studies of these novel ligands led to the discovery of several compounds with interesting in vitro pharmacological profiles.
引用
收藏
页码:5493 / 5508
页数:16
相关论文
共 50 条
  • [1] Synthesis of 3,6-diazabicyclo[3.1.1]heptanes as novel ligands for neuronal nicotinic acetylcholine receptors
    Murineddu, Gabriele
    Murruzzu, Caterina
    Curzu, Maria M.
    Chelucci, Giorgio
    Gotti, Cecilia
    Gaimarri, Annalisa
    Legnani, Laura
    Toma, Lucio
    Pinna, Gerard A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (23) : 6147 - 6150
  • [2] A-366833:: A novel nicotinonitrile-substituted 3,6-diazabicyclo[3.2.0]-heptane α4β2 nicotinic acetylcholine receptor selective agonist:: Synthesis, analgesic efficacy and tolerability profile in animal models
    Ji, Jianguo
    Bunnelle, William H.
    Anderson, David J.
    Faltynek, Connie
    Dyhrinq, Tino
    Ahring, Philip K.
    Rueter, Lynne E.
    Curzon, Peter
    Buckley, Michael J.
    Marsh, Kennan C.
    Kempf-Grote, Anita
    Meyer, Michael D.
    BIOCHEMICAL PHARMACOLOGY, 2007, 74 (08) : 1253 - 1262
  • [3] Synthesis of 3,6-diazabicyclo[3.1.1]heptanes as novel ligands for the opioid receptors
    Loriga, G
    Manca, I
    Murineddu, G
    Chelucci, G
    Villa, S
    Gessi, S
    Toma, L
    Cignarella, G
    Pinna, GA
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (03) : 676 - 691
  • [4] Design of novel 3,6-diazabicyclo[3.1.1]heptane derivatives with potent and selective affinities for α4β2 neuronal nicotinic acetylcholine receptors
    Deligia, Francesco
    Deiana, Valeria
    Gotti, Cecilia
    Lazzari, Paolo
    Bottazzi, Mirko E. H.
    Pucci, Luca
    Fasoli, Francesca
    Ragusa, Giulio
    Pinna, Gerard A.
    Murineddu, Gabriele
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 103 : 429 - 437
  • [5] MEDI 45-Synthesis and structure activity relationship (SAR) studies of {[3,6-diazabicyclo[3.2.0]-heptan-3-yl]pyridin-2-yl}-indoles as novel and potent α7 neuronal nicotinic receptors (NNRs) agonists with cognition-enhancing properties
    Ji, Jianguo
    Bunnelle, William H.
    Bitner, Robert S.
    Gopalakrishnan, Murali
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
  • [6] Quantitative Structure Activity Relationship between Diazabicyclo[4.2.0]octanes Derivatives and Nicotinic Acetylcholine Receptor Agonists
    Kim, Eun Ae
    Jung, Kyoung Chul
    Sohn, Uy Dong
    Im, Chaeuk
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2009, 13 (01): : 55 - 59
  • [7] Novel N-aryl nicotinamide derivatives: Taking stock on 3,6-diazabicyclo[3.1.1]heptanes as ligands for neuronal acetylcholine receptors
    Murineddu, Gabriele
    Gotti, Cecilia
    Asproni, Battistina
    Corona, Paola
    Martinello, Katiuscia
    Plutino, Simona
    Fucile, Sergio
    Temml, Veronika
    Moretti, Milena
    Viani, Paola
    Schuster, Daniela
    Piras, Sandra
    Deligia, Francesco
    Pinna, Gerard A.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 180 : 51 - 61
  • [8] Identification and pharmacological characterization of 3,6-diazabicyclo[3.1.1]heptane-3-carboxamides as novel ligands for the α4β2 and α6/α3β2β3 nicotinic acetylcholine receptors (nAChRs)
    Strachan, Jon-Paul
    Kombo, David C.
    Mazurov, Anatoly
    Heemstra, Ronald
    Bhatti, Balwinder S.
    Akireddy, Rao
    Murthy, Srinivasa
    Miao, Lan
    Jett, John E.
    Speake, Jason
    Bencherif, Merouane
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 86 : 60 - 74
  • [9] Syntheses and structure-activity relationship (SAR) studies of 2,5-diazabicyclo[2.2.1]heptanes as novel α7 neuronal nicotinic receptor (NNR) ligands
    Li, Tao
    Bunnelle, William H.
    Ryther, Keith B.
    Anderson, David J.
    Malysz, John
    Helfrich, Rosalind
    Gronlien, Jens H.
    Hakerud, Monika
    Peters, Dan
    Schrimpf, Michael R.
    Gopalakrishnan, Murali
    Ji, Jianguo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (12) : 3636 - 3639
  • [10] Synthesis and structure-activity relationships of 3,8-diazabicyclo[4.2.0]octane ligands, potent nicotinic acetylcholine receptor agonists
    Frost, Jennifer M.
    Bunnelle, William H.
    Tietje, Karin R.
    Anderson, David J.
    Rueter, Lynne E.
    Curzon, Peter
    Surowy, Carol S.
    Ji, Jianquo
    Daanen, Jerome F.
    Kohlhaas, Kathy L.
    Buckley, Michael J.
    Henry, Rodger F.
    Dyhring, Tino
    Ahring, Philip K.
    Meyer, Michael D.
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (26) : 7843 - 7853